Evidence map›Paper›PMID 39081220›Full record

ArticleBioconjugate chemistry2024

Synthesis and Structure Optimization of Star Copolymers as Tunable Macromolecular Carriers for Minimal Immunogen Vaccine Delivery.

Gabriela Mixová, Eva Tihlaříková, Yaling Zhu, Lucie Schindler, Ladislav Androvič, Lucie Kracíková, Eliška Hrdá, Bedřich Porsch, Michal Pechar, Christopher M Garliss and 7 more

Abstract read
In one paragraph

Article in Bioconjugate chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Gabriela MixováInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, Prague 162 06, Czech Republic.
Eva TihlaříkováInstitute of Scientific Instruments, Czech Academy of Sciences, Královopolská 147, Brno 612 64, Czech Republic.ORCID 0000-0002-7983-2971
Yaling ZhuBarinthus Biotherapeutics North America, Inc. (formerly Avidea Technologies, Inc.), 20400 Century Boulevard, Germantown, Maryland 20874, United States.
Lucie SchindlerInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, Prague 162 06, Czech Republic.
Ladislav AndrovičInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, Prague 162 06, Czech Republic.
Lucie KracíkováInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, Prague 162 06, Czech Republic.
Eliška HrdáInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, Prague 162 06, Czech Republic.
Bedřich PorschInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, Prague 162 06, Czech Republic.
Michal PecharInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, Prague 162 06, Czech Republic.ORCID 0000-0002-4507-1801
Christopher M GarlissBarinthus Biotherapeutics North America, Inc. (formerly Avidea Technologies, Inc.), 20400 Century Boulevard, Germantown, Maryland 20874, United States.
David WilsonBarinthus Biotherapeutics North America, Inc. (formerly Avidea Technologies, Inc.), 20400 Century Boulevard, Germantown, Maryland 20874, United States.
Hugh C WellesBarinthus Biotherapeutics North America, Inc. (formerly Avidea Technologies, Inc.), 20400 Century Boulevard, Germantown, Maryland 20874, United States.ORCID 0000-0002-3336-1203
Jake HolechekBarinthus Biotherapeutics North America, Inc. (formerly Avidea Technologies, Inc.), 20400 Century Boulevard, Germantown, Maryland 20874, United States.
Qiuyin RenVaccine Research Center, National Institutes of Health, Rockville, Maryland 20892, United States.
Geoffrey M LynnBarinthus Biotherapeutics North America, Inc. (formerly Avidea Technologies, Inc.), 20400 Century Boulevard, Germantown, Maryland 20874, United States.
Vilém NedělaInstitute of Scientific Instruments, Czech Academy of Sciences, Královopolská 147, Brno 612 64, Czech Republic.
Richard LagaInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, Prague 162 06, Czech Republic.ORCID 0000-0001-5420-2407

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Minimal immunogen vaccines are being developed to focus antibody responses against otherwise challenging targets, including human immunodeficiency virus (HIV), but multimerization of the minimal peptide immunogen on a carrier platform is required for activity. Star copolymers comprising multiple hydrophilic polymer chains ("arms") radiating from a central dendrimer unit ("core") were recently reported to be an effective platform for arraying minimal immunogens for inducing antibody responses in mice and primates. However, the impact of different parameters of the star copolymer (e.g., minimal immunogen density and hydrodynamic size) on antibody responses and the optimal synthetic route for controlling those parameters remains to be fully explored. We synthesized a library of star copolymers composed of poly[

Indexed as

DendrimersAIDS VaccinesAnimalsDrug CarriersHumansMicePolyaminesPolymersVaccinesAIDS VaccinesDendrimersDrug CarriersPoly(amidoamine)PolyaminesPolymersVaccines

Identifiers

PMID39081220
PMCPMC11342300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.